Carlsmed, Inc. (CARL)vsHinge Health, Inc. (HNGE)
CARL
Carlsmed, Inc.
$14.73
-0.20%
HEALTHCARE · Cap: $402.17M
HNGE
Hinge Health, Inc.
$88.59
+0.37%
HEALTHCARE · Cap: $7.37B
Smart Verdict
WallStSmart Research — data-driven comparison
Hinge Health, Inc. generates 1038% more annual revenue ($720.06M vs $63.30M). HNGE leads profitability with a 15.1% profit margin vs -57.4%. HNGE earns a higher WallStSmart Score of 52/100 (C-).
CARL
Avoid30
out of 100
Grade: F
HNGE
Buy52
out of 100
Grade: C-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 56.7% year-over-year
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Revenue surging 53.0% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of -43.1% — below average capital efficiency
Weak financial health signals
Trading at 20.7x book value
ROE of -197.2% — below average capital efficiency
Earnings declined 68.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : CARL
The strongest argument for CARL centers on Revenue Growth, Debt/Equity. Revenue growth of 56.7% demonstrates continued momentum.
Bull Case : HNGE
The strongest argument for HNGE centers on P/E Ratio, Revenue Growth, Debt/Equity. Profitability is solid with margins at 15.1% and operating margin at 19.0%. Revenue growth of 53.0% demonstrates continued momentum.
Bear Case : CARL
The primary concerns for CARL are EPS Growth, Altman Z-Score, Market Cap.
Bear Case : HNGE
The primary concerns for HNGE are Piotroski F-Score, Price/Book, Return on Equity.
Key Dynamics to Monitor
CARL profiles as a hypergrowth stock while HNGE is a growth play — different risk/reward profiles.
CARL is growing revenue faster at 56.7% — sustainability is the question.
HNGE generates stronger free cash flow (100M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
HNGE scores higher overall (52/100 vs 30/100), backed by strong 15.1% margins and 53.0% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Carlsmed, Inc.
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. The company is headquartered in Carlsbad, California.
Hinge Health, Inc.
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?